Life Sciences Health Industry China Briefing

more+
less-

Life Sciences Health Industry China Briefing summarizes the business, regulatory and legal developments during June 2011 in China important for drug, device, and life science/health care companies

News

Tianjin Pharma Firm to Build Base in US (Global Times 2011-06-03) - June 3, 2011

Tianjin-based pharmaceutical company Tasly Group is investing $40 million to build a production and training center in Maryland to help prepare for the entry of its Compound Danshen Dripping Pills (CDDP) into the American market, the company announced in Shanghai on Thursday. The 430,000 sq. ft. facility is expected to be complete within a year-and-a-half, and will serve as a base for further clinical trials of CDDP, as well as its future production, packaging and warehousing.

Media Forces Drug Firm to Act (Shanghai Daily 2011-06-09) - June 9, 2011

Media exposure of environmental contamination has forced Harbin Pharmaceutical Group Co. to reduce or even stop production until the company takes steps to solve the problem. The drug-maker admitted in a statement to the Shanghai Stock Exchange that it has "problems" in discharging waste water and incineration of industrial wastes. It agreed to cut back on production until its water processing system, which has been under repair since March, becomes operational in the middle of this month.

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Reed Smith | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×
Loading...
×